category,subcategory,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,19/285,112/8866,2.25113417627842e-09,6.7083798453097e-07,5.2842412769483e-07,PIK3CG/HSPA8/BCL2L1/CASP3/SOCS1/MAPK13/GNAO1/MAPK11/TNF/HSPA1B/LAMC1/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1/CIITA,19
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,17/285,100/8866,1.55857359327069e-08,2.32227465397333e-06,1.82927321736507e-06,ITGA4/IL3RA/IL2RA/CSF1/CD1E/CD1B/TNF/CSF3R/FCER2/CD1C/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,17
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,13/285,79/8866,1.17261245216593e-06,0.000116479503581816,9.17517813449132e-05,ITGA4/JUN/MAPK13/MAPK11/TNF/FCGR3A/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,13
Human Diseases,Immune disease,hsa05330,Allograft rejection,9/285,39/8866,2.93122415984445e-06,0.000158786397569734,0.000125077240049632,CD80/TNF/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,9
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,17/285,143/8866,3.07463146400248e-06,0.000158786397569734,0.000125077240049632,TGFBR1/MAP2K1/MITF/TNFRSF11A/SOCS3/TNFRSF11B/SOCS1/JUN/PPARG/MAPK13/CSF1/BTK/MAPK11/TNF/FCGR3A/LILRA6/FOSL2,17
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,10/285,50/8866,3.30943648995963e-06,0.000158786397569734,0.000125077240049632,CD80/ITGA4/HLA-DQB2/HLA-DOB/HLA-DOA/CXCR4/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,10
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,26/285,300/8866,3.72988182210785e-06,0.000158786397569734,0.000125077240049632,TGFBR1/HSPA8/MAP2K1/MAP3K13/CASP3/RPS6KA1/JUN/MAPK13/MAPKAPK3/HSPB1/MAP3K21/TGFA/CSF1/CACNA2D1/NR4A1/PDGFA/MAPK11/TNF/HSPA1B/FGF9/CACNB3/EFNA5/GNA12/PDGFC/RASGRP3/DUSP5,26
Human Diseases,Immune disease,hsa05310,Asthma,8/285,32/8866,5.55013341630346e-06,0.000206742469757304,0.000162852598925746,TNF/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,8
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,13/285,93/8866,7.70576439331464e-06,0.000220233332783897,0.000173479453234932,IL2RA/JUN/MAPK13/MAPK11/HLA-DQB2/DLL4/HLA-DOB/MAML3/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,13
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,9/285,44/8866,8.51422240142821e-06,0.000220233332783897,0.000173479453234932,CD80/TNF/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,9
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,12/285,81/8866,9.40984033728836e-06,0.000220233332783897,0.000173479453234932,HSPA8/RFXAP/TNF/HSPA1B/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1/CIITA,12
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,14/285,109/8866,9.4309239748474e-06,0.000220233332783897,0.000173479453234932,IRF4/TGFBR1/IL2RA/JUN/MAPK13/IL27/MAPK11/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,14
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,13/285,95/8866,9.78080482013462e-06,0.000220233332783897,0.000173479453234932,CD80/TNFRSF11A/JUN/CSF1/TNF/HLA-DQB2/CXCL8/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,13
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,9/285,45/8866,1.03465324126663e-05,0.000220233332783897,0.000173479453234932,CD80/TNF/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,9
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,24/285,298/8866,3.03930786050773e-05,0.000603809161620869,0.000475625019574192,CCL17/CCL22/TGFBR1/TNFRSF11A/IL3RA/RELT/IL2RA/TNFRSF11B/CCR6/CSF1/IL27/CD70/TNF/CCL8/CSF3R/TNFSF15/IL31RA/TNFRSF8/BMP6/CXCL8/CXCL13/ACKR3/CXCR4/ACVR2A,24
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,16/285,158/8866,4.5927089967812e-05,0.000855392050650499,0.000673798754133032,CD80/ITGA4/PTPRF/VCAN/NRCAM/CLDN12/HLA-DQB2/HLA-DOB/HLA-DOA/NRXN2/ITGAV/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1/ITGB8,16
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,16/285,159/8866,4.9610191970801e-05,0.000869637482782277,0.00068501998820363,TUBA1B/TUBB2A/TUBB2B/COLEC12/SEC61G/DYNC1I1/FCGR3A/MSR1/HLA-DQB2/HLA-DOB/HLA-DOA/ITGAV/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,16
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,10/285,70/8866,7.24317052779936e-05,0.00116967260267346,0.000921359909559097,CD80/CASP3/HLA-DQB2/HLA-DOB/HLA-DOA/DMD/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,10
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,17/285,182/8866,7.45764411100525e-05,0.00116967260267346,0.000921359909559097,CASP3/MAPK13/RFXAP/CYP27B1/SRC/ITGAX/MAPK11/TNF/FCGR3A/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1/CIITA,17
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,9/285,66/8866,0.000239287283589726,0.00356538052548692,0.00280847706528995,JUN/TNF/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,9
Human Diseases,Immune disease,hsa05320,Autoimmune thyroid disease,8/285,54/8866,0.000297145945267467,0.00421664246141453,0.00332148099221279,CD80/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,8
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,11/285,100/8866,0.000347904938188627,0.00471253052637321,0.00371209575196477,CCL17/CCL22/IL2RA/CCR6/CSF1/TNF/CCL8/CXCL8/CXCL13/ACKR3/CXCR4,11
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,19/285,251/8866,0.000455219272135227,0.0058980583954912,0.00464594497419476,PIK3CG/AHNAK/TXN/MAP2K1/TUBA1B/CASP3/TUBB2A/TUBB2B/JUN/MAPK13/NCKAP1/MAPK11/DYNC1I1/TNF/FHOD1/SNX33/CXCL8/ACTR3B/PIK3C2A,19
Cellular Processes,Cellular community - eukaryotes,hsa04540,Gap junction,10/285,92/8866,0.000706973863888809,0.00877825880995271,0.0069147005108423,MAP2K1/TUBA1B/TUBB2A/TUBB2B/SRC/PDGFA/PRKG1/GUCY1B1/GUCY1A1/PDGFC,10
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,16/285,204/8866,0.00087071915264499,0.0103789722995283,0.00817559457009823,CDKN1A/VIM/CASP3/JUN/MAPK13/BTK/MAPK11/TNF/FCER2/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,16
Cellular Processes,Cell motility,hsa04810,Regulation of actin cytoskeleton,17/285,230/8866,0.00117440855589694,0.0134605288329727,0.0106029598366404,ITGA4/MAP2K1/PIP5K1B/SRC/NCKAP1/PDGFA/ITGAX/FGF9/MYLK/ITGAE/ACTR3B/CXCR4/GNA12/ITGAV/PDGFC/RDX/ITGB8,17
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,13/285,155/8866,0.00143214740947607,0.015806664000884,0.0124510281603573,CDKN1A/CAMK1D/PIK3CG/MAP2K1/JUN/GNAO1/SRC/CACNA2D1/NPR1/MYLK/CACNB3/GUCY1B1/GUCY1A1,13
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,8/285,71/8866,0.00189689219620753,0.0196381033039764,0.0154690817265516,MAP2K1/CISH/TNFRSF11A/SOCS3/SOCS1/MAPK13/SRC/MAPK11,8
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,12/285,141/8866,0.00191109058998429,0.0196381033039764,0.0154690817265516,CD80/TNF/FCGR3A/H2AC20/HLA-DQB2/HLA-DOB/HLA-DOA/MACROH2A2/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,12
Metabolism,Amino acid metabolism,hsa00380,Tryptophan metabolism,6/285,42/8866,0.00207192995274204,0.0205811708639043,0.0162119431389991,EHHADH/MAOA/ALDH2/IDO1/IDO2/KYNU,6
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,15/285,203/8866,0.00226436842786998,0.0215174048158609,0.0169494216670328,MYO1C/TUBA1B/CASP3/TUBB2A/TUBB2B/JUN/MAPK13/SRC/NCKAP1/MAPK11/TNF/CLDN12/CXCL8/ACTR3B/GNA12,15
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,16/285,224/8866,0.00231059380573003,0.0215174048158609,0.0169494216670328,CDKN1A/TGFBR1/BCL2L1/MAP2K1/IL2RA/JUN/CREB5/TNF/MMP7/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,16
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,22/285,362/8866,0.00302964149183628,0.027358580744461,0.0215505598940826,ITGA4/CDKN1A/PIK3CG/BCL2L1/MAP2K1/IL3RA/IL2RA/PPP2R3A/CREB5/TGFA/CSF1/NR4A1/PDGFA/MLST8/VTN/CSF3R/FGF9/LAMC1/EFNA5/ITGAV/PDGFC/ITGB8,22
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,13/285,173/8866,0.00377987300867362,0.0328502285195147,0.0258763721647891,MAP2K1/CASP3/SOCS3/TNF/HLA-DQB2/CXCL8/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1/CIITA,13
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,11/285,134/8866,0.00385824831605039,0.0328502285195147,0.0258763721647891,MAP2K1/PPP1R14A/ADM/NPR1/MYLK/PRKG1/GUCY1B1/GUCY1A1/CALCRL/GNA12/RAMP1,11
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,9/285,99/8866,0.00445282238388807,0.0364085714103964,0.0286793056323504,ITGA4/CACNA2D1/EMD/TNF/CACNB3/TNNT2/ITGAV/DMD/ITGB8,9
,,hsa04148,Efferocytosis,12/285,157/8866,0.0046374681916228,0.0364085714103964,0.0286793056323504,MAP2K1/CASP3/PPARG/MAPK13/BSG/ODC1/MAPK11/XKR4/ITGAV/ADAM9/ANO6/DUSP5,12
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,11/285,138/8866,0.00482420072410662,0.0364085714103964,0.0286793056323504,ITGA4/MAP2K1/RPS6KA1/JUN/MAPK13/PIP5K1B/SRC/MAPK11/TNF/CXCL8/ACTR3B,11
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,12/285,158/8866,0.00487858925942649,0.0364085714103964,0.0286793056323504,MAP2K1/FNIP2/PRR5L/RPS6KA1/DEPTOR/GRB10/RRAGA/MLST8/TNF/FZD6/WNT2B/WNT5B,12
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,10/285,119/8866,0.00488705656515389,0.0364085714103964,0.0286793056323504,MAP2K1/CASP3/BCL3/SOCS3/JUN/MAPK13/CREB5/CSF1/MAPK11/TNF,10
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,14/285,203/8866,0.00580012186056316,0.0421569832792151,0.0332073729115683,ITGA4/MAP2K1/PARVB/JUN/PIP5K1B/EMP1/SRC/PDGFA/VTN/LAMC1/MYLK/ITGAV/PDGFC/ITGB8,14
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,14/285,204/8866,0.00605250106510529,0.0429439361286042,0.0338272615919419,CDKN1A/MAP2K1/CASP3/MAPK13/SRC/PLAU/MAPK11/VTN/TNF/FZD6/WNT2B/ITGAV/WNT5B/RDX,14
Human Diseases,Cardiovascular disease,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,8/285,86/8866,0.00625928264383226,0.0433782843688841,0.0341694009687783,ITGA4/CACNA2D1/EMD/CACNB3/DSG2/ITGAV/DMD/ITGB8,8
Human Diseases,Cardiovascular disease,hsa05414,Dilated cardiomyopathy,9/285,105/8866,0.00654476511410028,0.044325909181861,0.0349158521637407,ITGA4/CACNA2D1/EMD/TNF/CACNB3/TNNT2/ITGAV/DMD/ITGB8,9
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,6/285,60/8866,0.0122337821449097,0.0788087011351224,0.0620782068284433,MAP2K1/MAPK13/MAPKAPK3/HSPB1/SRC/MAPK11,6
Organismal Systems,Nervous system,hsa04730,Long-term depression,6/285,60/8866,0.0122337821449097,0.0788087011351224,0.0620782068284433,MAP2K1/GNAO1/PRKG1/GUCY1B1/GUCY1A1/GNA12,6
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,7/285,78/8866,0.0124295602461435,0.0788087011351224,0.0620782068284433,CASP3/JUN/MAPK13/SERPING1/MAPK11/TNF/CXCL8,7
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,7/285,80/8866,0.0141615813690971,0.0864148452204941,0.0680696237519258,BCL2L1/MAP2K1/TGFA/SRC/PDGFA/PDGFC/NRG2,7
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,14/285,226/8866,0.0142091524020276,0.0864148452204941,0.0680696237519258,CDKN1A/MAP2K1/CASP3/MAPK13/CREB5/GNAO1/STING1/SRC/MAPK11/TNF/CXCL8/CXCR4/GNA12/ITGAV,14
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,11/285,163/8866,0.0159249305516164,0.0949125860876339,0.0747633581686414,CDKN1A/TGFBR1/MAP2K1/CASP3/JUN/MAPK13/CREB5/SRC/MAPK11/TNF/CXCL8,11
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,8/285,102/8866,0.0167016298403725,0.0975899155378628,0.0768723107203936,FCGR3A/HLA-DQB2/HLA-DOB/HLA-DOA/HLA-DQB1/HLA-DQA1/HLA-DRB1/HLA-DPB1,8
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,8/285,103/8866,0.0176215514707593,0.100985044967044,0.0795466797161808,CASP3/HSPB1/CD1E/CD1B/TNF/CD1C/LAMC1/CXCL8,8
Metabolism,Amino acid metabolism,hsa00280,"Valine, leucine and isoleucine degradation",5/285,48/8866,0.0183592346581536,0.103227394870373,0.0813129956061223,AUH/EHHADH/AACS/BCAT1/ALDH2,5
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,11/285,168/8866,0.0195128843285983,0.106032353946917,0.0835224829747878,CDKN1A/BCL2L1/CISH/SOCS3/IL3RA/IL2RA/SOCS1/IL27/PDGFA/CSF3R/IL31RA,11
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,8/285,105/8866,0.0195697297553034,0.106032353946917,0.0835224829747878,CCL17/CCL22/BCL3/JUN/MAPK13/SRC/MAPK11/TNF,8
Organismal Systems,Immune system,hsa04611,Platelet activation,9/285,126/8866,0.0200887454879647,0.106900824203812,0.0842065835303783,PIK3CG/MAPK13/SRC/BTK/MAPK11/MYLK/PRKG1/GUCY1B1/GUCY1A1,9
Cellular Processes,Cellular community - eukaryotes,hsa04530,Tight junction,11/285,170/8866,0.0211042544188863,0.110334523102248,0.0869113339872879,TUBA1B/JUN/SRC/SCRIB/CD1E/CD1B/CD1C/CLDN12/RAB13/ACTR3B/RDX,11
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,6/285,71/8866,0.0261747646643368,0.134484135689179,0.105934165519911,CASP3/JUN/MAPK13/SRC/MAPK11/CXCL8,6
Human Diseases,Cancer: specific types,hsa05218,Melanoma,6/285,73/8866,0.0295184340802547,0.148463705165037,0.116945977576133,CDKN1A/MAP2K1/MITF/PDGFA/FGF9/PDGFC,6
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,10/285,157/8866,0.0298920211741685,0.148463705165037,0.116945977576133,ERN1/CASP3/SOCS3/JUN/PPARG/MAPK13/SREBF1/MAPK11/TNF/CXCL8,10
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,9/285,136/8866,0.0310407792505689,0.151641839617533,0.11944941799615,BCL2L1/MAP2K1/ERN1/TUBA1B/CASP3/IL3RA/LMNB2/JUN/TNF,9
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,7/285,95/8866,0.0329494029242764,0.157729969443477,0.124245083666179,CCL17/CASP3/JUN/MAPK13/MAPK11/TNF/CXCL8,7
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,5/285,56/8866,0.0333455975669095,0.157729969443477,0.124245083666179,HSPA8/CASP3/TNF/HSPA1B/CXCL8,5
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,9/285,139/8866,0.0350095285456812,0.163013117290828,0.128406658975114,HSPA8/MAP2K1/JUN/CREB5/GNAO1/TGFA/SRC/FKBP4/HSPA1B,9
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,9/285,141/8866,0.0378417006264303,0.171941731875867,0.135439795861244,TXN/JUN/MAPK13/SRC/PDGFA/MAPK11/TNF/ITGAV/ACVR2A,9
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,7/285,98/8866,0.0380810547107624,0.171941731875867,0.135439795861244,CDKN1A/MAP2K1/CREB5/TGFA/PLAU/PDGFA/PDGFC,7
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,7/285,99/8866,0.0399018972777356,0.175061880158718,0.137897560139153,CDKN1A/MAP2K1/JUN/MAPK13/SRC/MAPK11/DLL4,7
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,17/285,333/8866,0.0399744959685599,0.175061880158718,0.137897560139153,ITGA4/CDKN1A/MAP2K1/CASP3/PPP2R3A/CREB5/SCRIB/LFNG/VTN/TNF/LAMC1/FZD6/WNT2B/MAML3/ITGAV/WNT5B/ITGB8,17
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,12/285,212/8866,0.0407044887154761,0.175061880158718,0.137897560139153,MAP2K1/MAPK13/GNAO1/CSF1/SRC/PRKD1/PDGFA/MAPK11/FGF9/EFNA5/PDGFC/RASGRP3,12
Environmental Information Processing,Signal transduction,hsa04022,cGMP-PKG signaling pathway,10/285,166/8866,0.0413963385235914,0.175061880158718,0.137897560139153,PIK3CG/MAP2K1/CREB5/NPR1/MYLK/PRKG1/GUCY1B1/GUCY1A1/GNA12/ATP2B1,10
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,4/285,41/8866,0.0417093741317752,0.175061880158718,0.137897560139153,CDKN1A/MAP2K1/SRC/CXCL8,4
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,8/285,122/8866,0.0426480036864945,0.176515348591325,0.139042468159185,MAP2K1/MAPK13/PPP2R3A/MAPK11/TNF/S1PR3/SGMS2/GNA12,8
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,7/285,101/8866,0.0437120809275324,0.178441097484995,0.140559395051763,TGFBR1/CASP3/JUN/MAPK13/MAPK11/TNF/CXCL8,7
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,12/285,216/8866,0.0458400563381279,0.184599145794083,0.14541013603702,HSPA8/BCL2L1/ERN1/CASP3/JUN/PPARG/MAPK13/SRC/MAPK11/TNF/HSPA1B/CXCL8,12
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,7/285,103/8866,0.0477498810725541,0.189726194128282,0.149448750584976,TGFBR1/JUN/MAPK13/GNAO1/MAPK11/TNF/CXCL8,7
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,10/285,174/8866,0.0539011975718166,0.211349432584228,0.16648153820658,JUN/VANGL1/MMP7/FZD6/SERPINF1/CTNNBIP1/WNT2B/MCC/WNT5B/TBL1X,10
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,8/285,130/8866,0.0580113963948805,0.221782072386481,0.174699407072361,TGFBR1/MAP2K1/JUN/MAPK13/CREB5/GNAO1/SRC/MAPK11,8
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,6/285,86/8866,0.0580503410944481,0.221782072386481,0.174699407072361,CDKN1A/MAP2K1/JUN/TGFA/SRC/NRG2,6
Organismal Systems,Circulatory system,hsa04261,Adrenergic signaling in cardiomyocytes,9/285,154/8866,0.0600919844018415,0.222616033696623,0.175356324670953,PIK3CG/MAPK13/PPP2R3A/CREB5/CACNA2D1/MAPK11/CACNB3/TNNT2/ATP2B1,9
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,6/285,87/8866,0.0607516974531443,0.222616033696623,0.175356324670953,CDKN1A/TGFBR1/MAP2K1/CASP3/JUN/TGFA,6
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,7/285,109/8866,0.0612567609500775,0.222616033696623,0.175356324670953,CD80/MAP2K1/JUN/MAPK13/MAPK11/TNF/CXCL8,7
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,7/285,109/8866,0.0612567609500775,0.222616033696623,0.175356324670953,SOCS3/PTPRF/RPS6KA1/CREB5/SREBF1/TNF/GFPT2,7
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,6/285,88/8866,0.0635266857529059,0.228083763305614,0.179663296422296,SERPING1/PLAU/ITGAX/VTN/F5/TFPI,6
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,8/285,133/8866,0.064572147924554,0.229077381922822,0.180445977282901,CDKN1A/TGFBR1/CCNG2/MAP2K1/MAPK13/DEPP1/MAPK11/PLK2,8
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,5/285,69/8866,0.0704905667324275,0.24713163395604,0.194667447446828,MAP2K1/MAPK13/BTK/MAPK11/TNF,5
Metabolism,Amino acid metabolism,hsa00330,Arginine and proline metabolism,4/285,50/8866,0.0760880790370852,0.260623535092545,0.205295119483001,MAOA/ODC1/SAT2/ALDH2,4
Metabolism,Carbohydrate metabolism,hsa00520,Amino sugar and nucleotide sugar metabolism,4/285,50/8866,0.0760880790370852,0.260623535092545,0.205295119483001,UAP1/GMPPB/GNPDA1/GFPT2,4
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,5/285,72/8866,0.0813639494349162,0.271911231765519,0.214186523079162,MAPK13/STING1/MAPK11/TNF/CXCL8,5
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,11/285,213/8866,0.0820710555660797,0.271911231765519,0.214186523079162,BCL2L1/MAP2K1/CASP3/JUN/MAPK13/GNAO1/STING1/MAPK11/APOBEC3A/TNF/CXCR4,11
Metabolism,Glycan biosynthesis and metabolism,hsa00604,Glycosphingolipid biosynthesis - ganglio series,2/285,15/8866,0.0821208418083782,0.271911231765519,0.214186523079162,ST3GAL5/B4GALNT1,2
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,8/285,144/8866,0.0924396851941507,0.300855790205077,0.23698636953632,CASP3/MAPK13/SREBF1/MAPK11/TNF/CXCL8/SCD5/ALDH2,8
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,10/285,193/8866,0.092881653351903,0.300855790205077,0.23698636953632,CCL17/CCL22/PIK3CG/MAP2K1/CCR6/SRC/CCL8/CXCL8/CXCL13/CXCR4,10
Metabolism,Lipid metabolism,hsa00600,Sphingolipid metabolism,4/285,54/8866,0.0948171074839923,0.30213334262465,0.237992707189322,UGCG/B4GALNT1/SGMS2/B4GALT6,4
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,6/285,98/8866,0.095303806062809,0.30213334262465,0.237992707189322,CAMK1D/CREB5/NR4A1/PRKD1/NPR1/ATP2B1,6
Human Diseases,Cancer: specific types,hsa05214,Glioma,5/285,76/8866,0.0971643501536946,0.304789224692642,0.240084765476719,CDKN1A/CAMK1D/MAP2K1/TGFA/PDGFA,5
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,6/285,99/8866,0.0988781227586202,0.306934172729884,0.241774357183907,MAP2K1/JUN/PIP5K1B/CHKA/PDGFA/PDGFC,6
Human Diseases,Cancer: specific types,hsa05212,Pancreatic cancer,5/285,77/8866,0.101341078582289,0.307176503340792,0.241965242829377,CDKN1A/TGFBR1/BCL2L1/MAP2K1/TGFA,5
Metabolism,Lipid metabolism,hsa00120,Primary bile acid biosynthesis,2/285,17/8866,0.102048569901807,0.307176503340792,0.241965242829377,CYP27A1/CYP7B1,2
Metabolism,Metabolism of other amino acids,hsa00450,Selenocompound metabolism,2/285,17/8866,0.102048569901807,0.307176503340792,0.241965242829377,SEPHS1/PAPSS2,2
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,8/285,148/8866,0.10405567028911,0.310085897461547,0.244256994468121,CDKN1A/MAP2K1/JUN/FGF9/FZD6/DLL4/WNT2B/WNT5B,8
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,6/285,101/8866,0.106237122483945,0.312167021318458,0.245896311388259,MAP2K1/MITF/GNAO1/FZD6/WNT2B/WNT5B,6
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,8/285,149/8866,0.10708147908263,0.312167021318458,0.245896311388259,PIK3CG/MAP2K1/PIP5K1B/PDGFA/GRM7/CXCL8/GNA12/PDGFC,8
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,12/285,250/8866,0.107896655019467,0.312167021318458,0.245896311388259,BCL2L1/SEPTIN11/JUN/MAPK13/STING1/SRC/RRAGA/MAPK11/TNF/SEPTIN8/CXCL8/ACTR3B,12
Metabolism,Global and overview maps,hsa01250,Biosynthesis of nucleotide sugars,3/285,37/8866,0.114939182755567,0.323130910010934,0.254532649001902,UAP1/GMPPB/GFPT2,3
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,3/285,37/8866,0.114939182755567,0.323130910010934,0.254532649001902,TNF/IDO1/IDO2,3
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,3/285,37/8866,0.114939182755567,0.323130910010934,0.254532649001902,CDKN1A/MAP2K1/PPARG,3
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,8/285,153/8866,0.11966461213297,0.333271536594626,0.26252049685836,MTHFD2/GMPPB/AK8/BCAT1/ALDH2/IDO1/IDO2/KYNU,8
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,6/285,105/8866,0.121778030173857,0.333500095094309,0.262700534108198,BCL2L1/TNFRSF11A/BTK/PLAU/TNF/CXCL8,6
Human Diseases,Immune disease,hsa05340,Primary immunodeficiency,3/285,38/8866,0.121984934111677,0.333500095094309,0.262700534108198,RFXAP/BTK/CIITA,3
,,hsa04820,Cytoskeleton in muscle cells,11/285,232/8866,0.12773960748799,0.346058209376555,0.272592655213605,ITGA4/VIM/LMNB2/VCAN/EMD/DSG2/TNNT2/FBN1/ITGAV/DMD/ITGB8,11
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,4/285,63/8866,0.143835551984243,0.37942380791426,0.298874988219286,CDKN1A/FZD6/WNT2B/WNT5B,4
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,11/285,238/8866,0.14459969537244,0.37942380791426,0.298874988219286,BCL2L1/MAP2K1/PLAAT3/TGFA/CSF1/PDGFA/PLA1A/FGF9/EFNA5/PDGFC/RASGRP3,11
Metabolism,Glycan biosynthesis and metabolism,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,2/285,21/8866,0.145148705041026,0.37942380791426,0.298874988219286,CHST3/CHST7,2
Metabolism,Metabolism of cofactors and vitamins,hsa00770,Pantothenate and CoA biosynthesis,2/285,21/8866,0.145148705041026,0.37942380791426,0.298874988219286,BCAT1/ALDH2,2
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,3/285,42/8866,0.151635112839113,0.392932727183093,0.309516065566336,FTH1/SAT2/SLC7A11,3
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,7/285,138/8866,0.156034499924044,0.398459838147387,0.313869812458027,MAP2K1/PRKAR2B/SOCS3/PTPRF/SOCS1/SREBF1/PHKA1,7
Metabolism,Amino acid metabolism,hsa00340,Histidine metabolism,2/285,22/8866,0.156442285447129,0.398459838147387,0.313869812458027,MAOA/ALDH2,2
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,5/285,89/8866,0.157977845030228,0.398960998466169,0.314264580211783,ITGA4/VTN/LAMC1/ITGAV/ITGB8,5
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,5/285,90/8866,0.163194330516084,0.408671516754563,0.321913628527967,MAP2K1/JUN/MAPK13/BATF3/MAPK11,5
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",6/285,115/8866,0.16511714139875,0.41004090114023,0.322992302911591,CDKN1A/MAP2K1/CREB5/CYP27B1/GNA12/RUNX2,6
Organismal Systems,Excretory system,hsa04962,Vasopressin-regulated water reabsorption,3/285,44/8866,0.167240472520263,0.411531329618448,0.324166324637633,ARHGDIA/CREB5/DYNC1I1,3
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,5/285,91/8866,0.168479269172653,0.411531329618448,0.324166324637633,MAP2K1/JUN/BTK/LILRA6/RASGRP3,5
Organismal Systems,Endocrine system,hsa04912,GnRH signaling pathway,5/285,93/8866,0.179247046775205,0.421959581527718,0.332380737127097,MAP2K1/JUN/MAPK13/SRC/MAPK11,5
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,5/285,93/8866,0.179247046775205,0.421959581527718,0.332380737127097,CDKN1A/BCL2L1/CASP3/LAMC1/ITGAV,5
Metabolism,Glycan biosynthesis and metabolism,hsa00534,Glycosaminoglycan biosynthesis - heparan sulfate / heparin,2/285,24/8866,0.17948523989937,0.421959581527718,0.332380737127097,EXTL2/HS3ST1,2
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,9/285,196/8866,0.179909904573209,0.421959581527718,0.332380737127097,CDKN1A/PIK3CG/MAP2K1/CASP3/JUN/MAPK13/SRC/MAPK11/CXCL8,9
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,8/285,170/8866,0.1812076506983,0.421959581527718,0.332380737127097,CDKN1A/TGFBR1/BCL2L1/MAP2K1/TGFA/FZD6/WNT2B/WNT5B,8
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,7/285,144/8866,0.181244384011906,0.421959581527718,0.332380737127097,MAP2K1/MAPK13/MAPK11/FZD6/WNT2B/ACVR2A/WNT5B,7
Cellular Processes,Cell motility,hsa04814,Motor proteins,9/285,197/8866,0.183601337110016,0.424133321385929,0.334093008368287,MYO1C/TUBA1B/TUBB2A/TUBB2B/KIF3A/DYNC1I1/MYO7B/MYO3B/TNNT2,9
Human Diseases,Cancer: specific types,hsa05211,Renal cell carcinoma,4/285,70/8866,0.187481865855365,0.429766123268452,0.338530008791469,CDKN1A/MAP2K1/JUN/TGFA,4
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,6/285,120/8866,0.188946314969308,0.42981680809812,0.338569933613143,MAP2K1/ARHGDIA/RPS6KA1/JUN/MAPK13/MAPK11,6
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,3/285,47/8866,0.191464381142955,0.43224534530758,0.340482910644968,SOCS3/SOCS1/TNF,3
Organismal Systems,Immune system,hsa04660,T cell receptor signaling pathway,6/285,122/8866,0.198834212279574,0.442183546711291,0.34831130666414,MAP2K1/JUN/MAPK13/PPP2R3A/MAPK11/TNF,6
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",6/285,122/8866,0.198834212279574,0.442183546711291,0.34831130666414,MAP2K1/SOCS3/SOCS1/MAPK13/CREB5/MAPK11,6
Organismal Systems,Environmental adaptation,hsa04713,Circadian entrainment,5/285,97/8866,0.201520410194192,0.444837646206438,0.350401960805495,GNAO1/PRKG1/GUCY1B1/NOS1AP/GUCY1A1,5
Metabolism,Carbohydrate metabolism,hsa00562,Inositol phosphate metabolism,4/285,73/8866,0.20736237929376,0.449325080954993,0.353936746919687,PIK3CG/PIP5K1B/OCRL/PIK3C2A,4
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,7/285,150/8866,0.208040572929963,0.449325080954993,0.353936746919687,CDKN1A/TGFBR1/MAP2K1/FGF9/FZD6/WNT2B/WNT5B,7
Human Diseases,Substance dependence,hsa05030,Cocaine addiction,3/285,49/8866,0.208076715341574,0.449325080954993,0.353936746919687,JUN/CREB5/MAOA,3
Metabolism,Carbohydrate metabolism,hsa00650,Butanoate metabolism,2/285,27/8866,0.21488030519666,0.46067863991802,0.362880030737261,EHHADH/AACS,2
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,4/285,75/8866,0.220940707518764,0.470288077432798,0.370449456967552,CDKN1A/BCL2L1/CCNG2/CASP3,4
Metabolism,Glycan biosynthesis and metabolism,hsa00601,Glycosphingolipid biosynthesis - lacto and neolacto series,2/285,28/8866,0.22682586032301,0.478095191559249,0.37659917950446,GCNT2/B3GNT5,2
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,4/285,76/8866,0.227817171816823,0.478095191559249,0.37659917950446,EHHADH/PPARG/CYP27A1/SCD5,4
Metabolism,Nucleotide metabolism,hsa00230,Purine metabolism,6/285,128/8866,0.229583136603612,0.47843199096417,0.376864478929742,PFAS/NPR1/PAPSS2/GUCY1B1/GUCY1A1/AK8,6
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,7/285,155/8866,0.231439233683837,0.478950636373496,0.377273019820875,CDKN1A/MAP2K1/CREB5/NR4A1/FZD6/WNT2B/WNT5B,7
Human Diseases,Cancer: specific types,hsa05220,Chronic myeloid leukemia,4/285,77/8866,0.234747368706387,0.482446316375885,0.380026593259704,CDKN1A/TGFBR1/BCL2L1/MAP2K1,4
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,8/285,184/8866,0.240312531509303,0.486722526488373,0.383394996138846,SEMA7A/PLXNA3/SRC/PLXNA1/SEMA4C/EFNA5/CXCR4/WNT5B,8
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,7/285,157/8866,0.241040853830516,0.486722526488373,0.383394996138846,TGFBR1/TEAD1/SCRIB/BMP6/FZD6/WNT2B/WNT5B,7
Human Diseases,Infectious disease: bacterial,hsa05100,Bacterial invasion of epithelial cells,4/285,78/8866,0.241727966175434,0.486722526488373,0.383394996138846,SEPTIN11/SRC/SEPTIN8/ACTR3B,4
Cellular Processes,Transport and catabolism,hsa04137,Mitophagy - animal,5/285,105/8866,0.248571219036284,0.495108413302667,0.390000622276562,HUWE1/BCL2L1/MITF/JUN/SRC,5
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,2/285,30/8866,0.25083901100623,0.495108413302667,0.390000622276562,TNF/ABCC4,2
Organismal Systems,Nervous system,hsa04728,Dopaminergic synapse,6/285,132/8866,0.250877081908398,0.495108413302667,0.390000622276562,MAPK13/PPP2R3A/CREB5/GNAO1/MAOA/MAPK11,6
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,8/285,189/8866,0.262872338507763,0.508684228950723,0.400694394404843,BCL2L1/TXN/JUN/MAPK13/STING1/MAPK11/TNF/CXCL8,8
Metabolism,Metabolism of other amino acids,hsa00410,beta-Alanine metabolism,2/285,31/8866,0.26287708475977,0.508684228950723,0.400694394404843,EHHADH/ALDH2,2
Genetic Information Processing,"Folding, sorting and degradation",hsa03060,Protein export,2/285,31/8866,0.26287708475977,0.508684228950723,0.400694394404843,SEC11C/SEC61G,2
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,5/285,108/8866,0.26690735851003,0.51315092152251,0.404212841750334,TGFBR1/TNF/BMP6/FBN1/ACVR2A,5
Cellular Processes,Cell growth and death,hsa04215,Apoptosis - multiple species,2/285,32/8866,0.274917974436994,0.525163822962976,0.413675494598176,BCL2L1/CASP3,2
Metabolism,Energy metabolism,hsa00920,Sulfur metabolism,1/285,10/8866,0.278845220917752,0.529273094480828,0.416912398690303,PAPSS2,1
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,11/285,278/8866,0.282317757325505,0.53247273217089,0.419432777372336,HSPA8/TUBA1B/CASP3/TUBB2A/TUBB2B/MAPK13/CREB5/MAPK11/TNF/HSPA1B/LAMC1,11
Human Diseases,Infectious disease: viral,hsa05162,Measles,6/285,139/8866,0.289363180839581,0.542328477296824,0.427196221961115,HSPA8/BCL2L1/CASP3/IL2RA/JUN/HSPA1B,6
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,10/285,252/8866,0.292334837088206,0.543289282148908,0.427953055172047,TGFBR1/HSPA8/RAB11FIP1/IL2RA/PIP5K1B/SRC/HSPA1B/ACTR3B/CXCR4/PSD3,10
Organismal Systems,Endocrine system,hsa04923,Regulation of lipolysis in adipocytes,3/285,59/8866,0.294743567929428,0.543289282148908,0.427953055172047,PLAAT3/NPR1/PRKG1,3
Organismal Systems,Environmental adaptation,hsa04710,Circadian rhythm,2/285,34/8866,0.298958694206434,0.543289282148908,0.427953055172047,BHLHE40/NFIL3,2
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,10/285,254/8866,0.30064970256755,0.543289282148908,0.427953055172047,CAMK1D/TGFA/PDGFA/PHKA1/FGF9/MYLK/ORAI2/CXCR4/PDGFC/ATP2B1,10
Cellular Processes,Transport and catabolism,hsa04140,Autophagy - animal,7/285,169/8866,0.301004622585986,0.543289282148908,0.427953055172047,BCL2L1/MAP2K1/ERN1/DEPTOR/RRAGA/MLST8/TP53INP2,7
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,12/285,312/8866,0.302624216111963,0.543289282148908,0.427953055172047,CDKN1A/FSCN1/VIM/MAP2K1/CASP3/SOCS1/PLAU/PDGFA/EFNA5/ZFPM2/RDX/ZEB2,12
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,8/285,198/8866,0.304936688647084,0.543289282148908,0.427953055172047,CDKN1A/BCL2L1/MITF/PPARG/PLAU/PDGFA/CXCL8/RUNX2,8
Genetic Information Processing,"Folding, sorting and degradation",hsa04141,Protein processing in endoplasmic reticulum,7/285,170/8866,0.306149277820427,0.543289282148908,0.427953055172047,HSPA8/ERN1/UBQLN4/OSTC/SEC61G/CKAP4/HSPA1B,7
Organismal Systems,Circulatory system,hsa04260,Cardiac muscle contraction,4/285,87/8866,0.306283890607438,0.543289282148908,0.427953055172047,SLC9A7/CACNA2D1/CACNB3/TNNT2,4
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,5/285,115/8866,0.310729011740564,0.547912695258509,0.431594952464315,MAP2K1/APP/CASP3/GNAO1/MAOA,5
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,5/285,116/8866,0.317078237999728,0.555819499552464,0.437823201696218,ITGA4/MAPK13/MAPK11/CLDN12/CXCR4,5
Environmental Information Processing,Signal transduction,hsa04330,Notch signaling pathway,3/285,62/8866,0.321336546063984,0.559990004251855,0.441108339626152,LFNG/DLL4/MAML3,3
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,3/285,63/8866,0.330211595767971,0.572110788016601,0.450655972192519,PLAAT3/GGT5/PTGR1,3
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,4/285,93/8866,0.350306026104166,0.603417316641858,0.475316360336045,TGFBR1/HEG1/PTPRF/SRC,4
Environmental Information Processing,Signal transduction,hsa04152,AMPK signaling pathway,5/285,122/8866,0.355449653718746,0.608758602345899,0.479523731272114,PPARG/PPP2R3A/CREB5/SREBF1/SCD5,5
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,2/285,39/8866,0.358322738896812,0.610172435378571,0.480637418189408,MTHFD2/ALDH1L2,2
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,10/285,271/8866,0.373308429945605,0.6320790461579,0.497893420322189,BCL2L1/TXN/ERN1/TUBA1B/CASP3/TUBB2A/TUBB2B/MAOA/SLC39A13/LRRK2,10
Organismal Systems,Digestive system,hsa04970,Salivary secretion,4/285,97/8866,0.379726777933849,0.638038983782595,0.502588108030798,PRKG1/GUCY1B1/GUCY1A1/ATP2B1,4
Organismal Systems,Endocrine system,hsa04924,Renin secretion,3/285,69/8866,0.383251604352633,0.638038983782595,0.502588108030798,NPR1/GUCY1B1/GUCY1A1,3
Human Diseases,Substance dependence,hsa05031,Amphetamine addiction,3/285,69/8866,0.383251604352633,0.638038983782595,0.502588108030798,JUN/CREB5/MAOA,3
Metabolism,Metabolism of cofactors and vitamins,hsa00730,Thiamine metabolism,1/285,15/8866,0.3876755374375,0.641818389757639,0.505565174552998,AK8,1
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,6/285,157/8866,0.392390883220438,0.6457699248233,0.508677828454949,CDKN1A/TGFBR1/MAP2K1/MAPK13/MAPK11/CXCL8,6
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,4/285,99/8866,0.394396397039734,0.6457699248233,0.508677828454949,MAP2K1/PIP5K1B/FCGR3A/ACTR3B,4
Human Diseases,Infectious disease: viral,hsa05160,Hepatitis C,6/285,159/8866,0.403954431170281,0.652703685021623,0.514139603531692,CDKN1A/MAP2K1/CASP3/SOCS3/TNF/CLDN12,6
Metabolism,Lipid metabolism,hsa00071,Fatty acid degradation,2/285,43/8866,0.404482317531649,0.652703685021623,0.514139603531692,EHHADH/ALDH2,2
Metabolism,Amino acid metabolism,hsa00360,Phenylalanine metabolism,1/285,16/8866,0.407392232932959,0.652703685021623,0.514139603531692,MAOA,1
Metabolism,Glycan biosynthesis and metabolism,hsa00603,Glycosphingolipid biosynthesis - globo and isoglobo series,1/285,16/8866,0.407392232932959,0.652703685021623,0.514139603531692,GBGT1,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,13/285,371/8866,0.415127167352183,0.661539550112035,0.521099680943072,ANXA11/BCL2L1/ERN1/TUBA1B/CASP3/TUBB2A/TUBB2B/UBQLN4/MAPK13/MAPK11/ALYREF/TNF/NRG2,13
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,3/285,73/8866,0.418112012894339,0.662752020438899,0.52205475294198,CDKN1A/MAP2K1/TGFA,3
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,4/285,103/8866,0.423559141438522,0.666616583990956,0.525098898728305,PLAAT3/CHKA/PLA1A/SGMS2,4
Metabolism,Metabolism of other amino acids,hsa00430,Taurine and hypotaurine metabolism,1/285,17/8866,0.426476211872407,0.666616583990956,0.525098898728305,GGT5,1
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,7/285,193/8866,0.427260964906955,0.666616583990956,0.525098898728305,MAP2K1/MAPK13/SRC/MAPK11/FCGR3A/H2AC20/MACROH2A2,7
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,3/285,75/8866,0.435305947391956,0.675631105847932,0.532199705418894,CDKN1A/BCL2L1/CASP3,3
Metabolism,Lipid metabolism,hsa00061,Fatty acid biosynthesis,1/285,18/8866,0.444947709173386,0.687017706392068,0.541169016338506,OLAH,1
Metabolism,Carbohydrate metabolism,hsa00620,Pyruvate metabolism,2/285,47/8866,0.449004102384629,0.689707332528967,0.543287655082867,PC/ALDH2,2
Metabolism,Lipid metabolism,hsa00100,Steroid biosynthesis,1/285,20/8866,0.480130994417222,0.727817605734381,0.57330740402249,CYP27B1,1
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,4/285,111/8866,0.480707530558201,0.727817605734381,0.57330740402249,MAP2K1/RPS6KA1/MAPK13/MAPK11,4
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,2/285,50/8866,0.48114116889152,0.727817605734381,0.57330740402249,TNF/CXCL8,2
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,8/285,235/8866,0.485635812005321,0.730684873923793,0.575565972748166,RPS6KA1/PPARG/MAPK13/CREB5/MAPK11/MLST8/NPR1/PRKG1,8
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,16/285,483/8866,0.487940570170586,0.730684873923793,0.575565972748166,BCL2L1/MAP2K1/ERN1/APP/TUBA1B/CASP3/TUBB2A/TUBB2B/MAPK13/CSF1/MAPK11/TNF/FZD6/WNT2B/LRRK2/WNT5B,16
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,13/285,391/8866,0.49123748425258,0.731943851536344,0.576557678885923,MAP2K1/ERN1/APP/TUBA1B/CASP3/TUBB2A/TUBB2B/CSF1/SLC39A13/TNF/FZD6/WNT2B/WNT5B,13
Genetic Information Processing,Chromosome,hsa03083,Polycomb repressive complex,3/285,83/8866,0.501965946467924,0.740524020036838,0.583316342169604,SUZ12/RNF2/BCORL1,3
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,3/285,83/8866,0.501965946467924,0.740524020036838,0.583316342169604,CASP3/STING1/DDX41,3
Organismal Systems,Nervous system,hsa04725,Cholinergic synapse,4/285,116/8866,0.515293851375221,0.756441220245398,0.595854440532404,PIK3CG/MAP2K1/CREB5/GNAO1,4
Human Diseases,Cancer: overview,hsa05207,Chemical carcinogenesis - receptor activation,7/285,215/8866,0.540886483359254,0.787636500687228,0.620427197644832,MAP2K1/RPS6KA1/JUN/CREB5/SRC/FGF9/DLL4,7
Environmental Information Processing,Signal transduction,hsa04340,Hedgehog signaling pathway,2/285,56/8866,0.541830478660677,0.787636500687228,0.620427197644832,KIF3A/IQCE,2
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,3/285,89/8866,0.549234519802237,0.793885412559522,0.62534951254247,GNAO1/SRC/SLC38A5,3
Metabolism,Global and overview maps,hsa01212,Fatty acid metabolism,2/285,57/8866,0.551457316777923,0.793885412559522,0.62534951254247,EHHADH/SCD5,2
Human Diseases,Substance dependence,hsa05034,Alcoholism,6/285,188/8866,0.565733129372087,0.805295641679439,0.634337435869004,MAP2K1/CREB5/GNAO1/MAOA/H2AC20/MACROH2A2,6
Metabolism,Metabolism of other amino acids,hsa00480,Glutathione metabolism,2/285,59/8866,0.570281536012997,0.805295641679439,0.634337435869004,ODC1/GGT5,2
Human Diseases,Cancer: specific types,hsa05213,Endometrial cancer,2/285,59/8866,0.570281536012997,0.805295641679439,0.634337435869004,CDKN1A/MAP2K1,2
Metabolism,Lipid metabolism,hsa00592,alpha-Linolenic acid metabolism,1/285,26/8866,0.572894886026983,0.805295641679439,0.634337435869004,PLAAT3,1
Organismal Systems,Digestive system,hsa04977,Vitamin digestion and absorption,1/285,26/8866,0.572894886026983,0.805295641679439,0.634337435869004,SLC5A6,1
Metabolism,Lipid metabolism,hsa01040,Biosynthesis of unsaturated fatty acids,1/285,27/8866,0.58666467759738,0.819540181503172,0.645557967061841,SCD5,1
Organismal Systems,Digestive system,hsa04978,Mineral absorption,2/285,61/8866,0.588528855173419,0.819540181503172,0.645557967061841,FTH1/ATP2B1,2
Organismal Systems,Aging,hsa04213,Longevity regulating pathway - multiple species,2/285,62/8866,0.597435265477066,0.824610436339106,0.649551844943909,HSPA8/HSPA1B,2
Metabolism,Metabolism of cofactors and vitamins,hsa00790,Folate biosynthesis,1/285,28/8866,0.599992041200135,0.824610436339106,0.649551844943909,MOCOS,1
Metabolism,Amino acid metabolism,hsa00310,Lysine degradation,2/285,63/8866,0.606196697270807,0.824610436339106,0.649551844943909,EHHADH/ALDH2,2
Environmental Information Processing,Signal transduction,hsa04392,Hippo signaling pathway - multiple species,1/285,29/8866,0.612891143741203,0.824610436339106,0.649551844943909,TEAD1,1
Genetic Information Processing,Information processing in viruses,hsa03250,Viral life cycle - HIV-1,2/285,64/8866,0.614813235858474,0.824610436339106,0.649551844943909,APOBEC3A/CXCR4,2
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,3/285,98/8866,0.614953326731641,0.824610436339106,0.649551844943909,PIP5K1B/OCRL/PIK3C2A,3
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,3/285,99/8866,0.621845730784514,0.824610436339106,0.649551844943909,MAPK13/SRC/MAPK11,3
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,2/285,65/8866,0.62328511040108,0.824610436339106,0.649551844943909,CREB5/NR4A1,2
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,2/285,65/8866,0.62328511040108,0.824610436339106,0.649551844943909,MAP2K1/KCNN1,2
Metabolism,Carbohydrate metabolism,hsa00020,Citrate cycle (TCA cycle),1/285,30/8866,0.625375700042409,0.824610436339106,0.649551844943909,PC,1
Metabolism,Carbohydrate metabolism,hsa00053,Ascorbate and aldarate metabolism,1/285,30/8866,0.625375700042409,0.824610436339106,0.649551844943909,ALDH2,1
Metabolism,Lipid metabolism,hsa00591,Linoleic acid metabolism,1/285,30/8866,0.625375700042409,0.824610436339106,0.649551844943909,PLAAT3,1
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,4/285,134/8866,0.629792551456227,0.826776124819187,0.65125777405397,MAP2K1/CASP3/TNF/FCGR3A,4
Metabolism,Carbohydrate metabolism,hsa00630,Glyoxylate and dicarboxylate metabolism,1/285,31/8866,0.637458987218497,0.8277890973537,0.652055700140852,HYI,1
,,hsa04981,Folate transport and metabolism,1/285,31/8866,0.637458987218497,0.8277890973537,0.652055700140852,ABCC4,1
Organismal Systems,Nervous system,hsa04720,Long-term potentiation,2/285,67/8866,0.639796448084307,0.8277890973537,0.652055700140852,MAP2K1/RPS6KA1,2
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,7/285,238/8866,0.648661393320951,0.8277890973537,0.652055700140852,RPL10/JUN/MAPK13/STING1/MAPK11/TNF/CXCL8,7
Metabolism,Carbohydrate metabolism,hsa00640,Propanoate metabolism,1/285,32/8866,0.649153858598545,0.8277890973537,0.652055700140852,EHHADH,1
Cellular Processes,Transport and catabolism,hsa04136,Autophagy - other,1/285,32/8866,0.649153858598545,0.8277890973537,0.652055700140852,MLST8,1
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,6/285,205/8866,0.650210289754046,0.8277890973537,0.652055700140852,CDKN1A/CASP3/JUN/CREB5/SRC/SCRIB,6
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,4/285,139/8866,0.658364520502606,0.8277890973537,0.652055700140852,MAP2K1/RPS6KA1/MAPK13/MAPK11,4
,,hsa01210,2-Oxocarboxylic acid metabolism,1/285,33/8866,0.660472757206132,0.8277890973537,0.652055700140852,BCAT1,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04130,SNARE interactions in vesicular transport,1/285,33/8866,0.660472757206132,0.8277890973537,0.652055700140852,VAMP5,1
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,2/285,70/8866,0.663491481245241,0.8277890973537,0.652055700140852,SOCS3/TNF,2
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,4/285,140/8866,0.663897967340719,0.8277890973537,0.652055700140852,TGFBR1/PIK3CG/MAP2K1/MYLK,4
Metabolism,Carbohydrate metabolism,hsa00051,Fructose and mannose metabolism,1/285,34/8866,0.671427728812183,0.833689429941794,0.65670343651367,GMPPB,1
Genetic Information Processing,Translation,hsa03013,Nucleocytoplasmic transport,3/285,108/8866,0.680057547281256,0.840901033567695,0.662384070948767,AHCTF1/ALYREF/IPO13,3
Metabolism,Amino acid metabolism,hsa00350,Tyrosine metabolism,1/285,36/8866,0.692292163273645,0.848983805166857,0.668750930950933,MAOA,1
Metabolism,Glycan biosynthesis and metabolism,hsa00512,Mucin type O-glycan biosynthesis,1/285,36/8866,0.692292163273645,0.848983805166857,0.668750930950933,GCNT1,1
Metabolism,Global and overview maps,hsa01230,Biosynthesis of amino acids,2/285,75/8866,0.700183312135795,0.852139989334589,0.67123708096649,PC/BCAT1,2
Metabolism,Amino acid metabolism,hsa00250,"Alanine, aspartate and glutamate metabolism",1/285,37/8866,0.702223843167984,0.852139989334589,0.67123708096649,GFPT2,1
Genetic Information Processing,Transcription,hsa03040,Spliceosome,6/285,217/8866,0.703444420725869,0.852139989334589,0.67123708096649,HSPA8/PUF60/ALYREF/HSPA1B/RNU4-1/RNU4-2,6
Metabolism,Amino acid metabolism,hsa00260,"Glycine, serine and threonine metabolism",1/285,41/8866,0.738856653921073,0.888748455929721,0.700073845539836,MAOA,1
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,6/285,226/8866,0.739629587485136,0.888748455929721,0.700073845539836,MAP2K1/JUN/CREB5/NPR1/ATP2B1/ABCC4,6
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,6/285,227/8866,0.743449569642951,0.889750890576705,0.700863470853427,MAP2K1/JUN/MAPK13/SRC/PRKD1/MAPK11,6
Metabolism,Glycan biosynthesis and metabolism,hsa00513,Various types of N-glycan biosynthesis,1/285,42/8866,0.747290178412007,0.890769892667113,0.701666146466853,OSTC,1
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,3/285,122/8866,0.756981659433176,0.895641339589868,0.70550342185991,MAP2K1/SRC/ITGAV,3
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,4/285,159/8866,0.757387978445123,0.895641339589868,0.70550342185991,FTH1/TNF/H2AC20/MACROH2A2,4
Organismal Systems,Endocrine system,hsa04911,Insulin secretion,2/285,86/8866,0.769289195426255,0.904555187302196,0.712524926769303,KCNN1/CREB5,2
Environmental Information Processing,Membrane transport,hsa02010,ABC transporters,1/285,45/8866,0.770996703271,0.904555187302196,0.712524926769303,ABCC4,1
Metabolism,Metabolism of cofactors and vitamins,hsa00860,Porphyrin metabolism,1/285,46/8866,0.778395630781233,0.909654501854146,0.716541695208317,FTH1,1
Metabolism,Glycan biosynthesis and metabolism,hsa00514,Other types of O-glycan biosynthesis,1/285,47/8866,0.785556316181159,0.91443664930463,0.720308628735191,LFNG,1
Organismal Systems,Aging,hsa04211,Longevity regulating pathway,2/285,90/8866,0.790765148886772,0.915352513856368,0.721030062133416,PPARG/CREB5,2
,,hsa03272,Virion - Hepatitis viruses,1/285,48/8866,0.792486404613903,0.915352513856368,0.721030062133416,CLDN12,1
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,1/285,50/8866,0.805684156482418,0.926531240087594,0.729835628892736,PLAAT3,1
Organismal Systems,Digestive system,hsa04979,Cholesterol metabolism,1/285,51/8866,0.811965918665099,0.926531240087594,0.729835628892736,CYP27A1,1
Human Diseases,Infectious disease: bacterial,hsa05110,Vibrio cholerae infection,1/285,51/8866,0.811965918665099,0.926531240087594,0.729835628892736,SEC61G,1
Metabolism,Amino acid metabolism,hsa00270,Cysteine and methionine metabolism,1/285,52/8866,0.818045296223856,0.926531240087594,0.729835628892736,BCAT1,1
Organismal Systems,Endocrine system,hsa04913,Ovarian steroidogenesis,1/285,52/8866,0.818045296223856,0.926531240087594,0.729835628892736,BMP6,1
Metabolism,Glycan biosynthesis and metabolism,hsa00510,N-Glycan biosynthesis,1/285,53/8866,0.823928787326216,0.926531240087594,0.729835628892736,OSTC,1
Organismal Systems,Excretory system,hsa04961,Endocrine and other factor-regulated calcium reabsorption,1/285,53/8866,0.823928787326216,0.926531240087594,0.729835628892736,ATP2B1,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,3/285,142/8866,0.84029474349926,0.94138283294278,0.741534340325821,HUWE1/SOCS3/SOCS1,3
Genetic Information Processing,Translation,hsa03015,mRNA surveillance pathway,2/285,103/8866,0.848862604579556,0.947419686010141,0.746289614907317,PPP2R3A/ALYREF,2
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,2/285,105/8866,0.856376500514982,0.94885969329467,0.747423919479729,KCNK5/COL14A1,2
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,3/285,149/8866,0.863008171206723,0.94885969329467,0.747423919479729,MAPK13/GNAO1/MAPK11,3
Organismal Systems,Endocrine system,hsa04922,Glucagon signaling pathway,2/285,107/8866,0.863548783585147,0.94885969329467,0.747423919479729,CREB5/PHKA1,2
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,2/285,109/8866,0.87039241982945,0.94885969329467,0.747423919479729,CDKN1A/MAP2K1,2
Metabolism,Lipid metabolism,hsa00140,Steroid hormone biosynthesis,1/285,63/8866,0.873279053563874,0.94885969329467,0.747423919479729,CYP7B1,1
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,7/285,311/8866,0.878193540182298,0.94885969329467,0.747423919479729,ERN1/TUBA1B/CASP3/TUBB2A/TUBB2B/PPARG/CREB5,7
Metabolism,Lipid metabolism,hsa00561,Glycerolipid metabolism,1/285,65/8866,0.881351944578286,0.94885969329467,0.747423919479729,ALDH2,1
Genetic Information Processing,Translation,hsa00970,Aminoacyl-tRNA biosynthesis,1/285,66/8866,0.885194087038823,0.94885969329467,0.747423919479729,WARS1,1
Cellular Processes,Cell growth and death,hsa04110,Cell cycle,3/285,158/8866,0.888021862150037,0.94885969329467,0.747423919479729,CDKN1A/PDS5B/CDC14B,3
Metabolism,Carbohydrate metabolism,hsa00010,Glycolysis / Gluconeogenesis,1/285,67/8866,0.888912233083588,0.94885969329467,0.747423919479729,ALDH2,1
Organismal Systems,Nervous system,hsa04724,Glutamatergic synapse,2/285,116/8866,0.891937782382206,0.94885969329467,0.747423919479729,GNAO1/GRM7,2
Metabolism,Metabolism of cofactors and vitamins,hsa00830,Retinol metabolism,1/285,68/8866,0.892510370777778,0.94885969329467,0.747423919479729,ALDH1A2,1
Human Diseases,Cancer: specific types,hsa05221,Acute myeloid leukemia,1/285,68/8866,0.892510370777778,0.94885969329467,0.747423919479729,MAP2K1,1
Genetic Information Processing,Chromosome,hsa03082,ATP-dependent chromatin remodeling,2/285,117/8866,0.894730113475846,0.94885969329467,0.747423919479729,H2AC20/MACROH2A2,2
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,4/285,205/8866,0.9006753649065,0.950464915063012,0.74868836474409,TGFBR1/MAPK13/MAPK11/GFPT2,4
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,1/285,71/8866,0.902622721351787,0.950464915063012,0.74868836474409,MAP2K1,1
Metabolism,Xenobiotics biodegradation and metabolism,hsa00982,Drug metabolism - cytochrome P450,1/285,73/8866,0.908831793334851,0.953633360611921,0.751184173141852,MAOA,1
Organismal Systems,Endocrine system,hsa04918,Thyroid hormone synthesis,1/285,75/8866,0.914646256486822,0.954113729334564,0.751562563198897,CREB5,1
Organismal Systems,Digestive system,hsa04971,Gastric acid secretion,1/285,76/8866,0.917413383878615,0.954113729334564,0.751562563198897,MYLK,1
Genetic Information Processing,Translation,hsa03010,Ribosome,3/285,172/8866,0.918894766171208,0.954113729334564,0.751562563198897,MRPS6/RPL10/MRPL24,3
Cellular Processes,Transport and catabolism,hsa04146,Peroxisome,1/285,83/8866,0.934434861029175,0.966561204054201,0.761367532688403,EHHADH,1
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,1/285,85/8866,0.938621112071682,0.966561204054201,0.761367532688403,AK8,1
Organismal Systems,Sensory system,hsa04742,Taste transduction,1/285,86/8866,0.940613252267511,0.966561204054201,0.761367532688403,KCNK5,1
Organismal Systems,Digestive system,hsa04976,Bile secretion,1/285,90/8866,0.947957871370935,0.969161249692328,0.763415608199891,ABCC4,1
Human Diseases,Substance dependence,hsa05032,Morphine addiction,1/285,91/8866,0.949647935940133,0.969161249692328,0.763415608199891,GNAO1,1
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,1/285,106/8866,0.969327363207747,0.985868785788084,0.776576260087399,ATP2B1,1
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,1/285,116/8866,0.977969110091214,0.990759988147279,0.780429096986377,PC,1
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,6/285,368/8866,0.98078589430687,0.990759988147279,0.780429096986377,GRM7/S1PR3/ADM/PGRMC1/NPFFR1/CALCRL,6
Human Diseases,Neurodegenerative disease,hsa05017,Spinocerebellar ataxia,1/285,144/8866,0.99129580741741,0.997993752062122,0.786127187247804,ERN1,1
Genetic Information Processing,Translation,hsa03008,Ribosome biogenesis in eukaryotes,1/285,168/8866,0.99608266589925,0.999436479589147,0.787263634575697,TBL3,1
Organismal Systems,Sensory system,hsa04740,Olfactory transduction,1/285,453/8866,0.999999749126836,0.999999749126836,0.787707326228486,PRKG1,1
